Choosing cell death and inflammation antibodies: why a caspase 3 antibody must be bought as a cleaved caspase 3 antibody or cleaved caspase-3 antibody rather than a total caspase antibody, what a gasdermin d antibody, an hmgb1 antibody, a nod2 antibody and a samhd1 antibody each report, and the controls that separate a real death signal from a dying culture

Reading each marker correctly

1. Read the cleaved form, not the total. The executioner caspase is present as an inactive precursor in healthy cells and is activated by cleavage. An antibody against the total protein shows no change during apoptosis; one specific for the cleaved neoepitope is the measurement. Buy the cleavage-specific reagent and say which you used.
2. Read gasdermin the same way. The pore-forming fragment is generated by cleavage, and the full length protein sits in healthy cells. A blot showing total gasdermin tells you the cell has the protein; the cleaved band tells you the pathway ran.
3. Read HMGB1 by location, not level. It is a nuclear protein that relocates to the cytoplasm and is released, so the informative measurements are a nuclear to cytoplasmic ratio by imaging or fractionation, and its appearance in the medium. A whole-cell level barely moves.
4. Include a positive control that definitely triggers the pathway. A known inducer at a known concentration, run alongside, is what shows the assay can detect the event. A negative result with no positive control is uninterpretable, and cell death assays are where that omission is most common.
5. Separate specific death from a sick culture. Confluence, medium exhaustion, handling and a poor thaw all cause background death that looks like a treatment effect. Include a vehicle control from the same plate and a viability measure, and report the baseline rather than only the difference.

Choosing between imaging, blotting and cytometry

A blot gives a population average and shows the cleavage products clearly. Imaging shows which cells and where the protein went, which is essential for a relocation readout. Cytometry counts the fraction of cells positive, which is usually the number a conclusion needs.

Most robust conclusions use two of the three. A cleavage band on a blot plus a per-cell fraction by cytometry is far stronger than either alone.

Timing decides what you see

Death markers are transient: cleaved caspase appears and then the cell fragments, and a single late time point can show less signal than an earlier one. Run a time course before choosing an endpoint.

For released markers, the medium accumulates the signal over time while the cellular signal falls. Sampling both makes the picture coherent where either alone is confusing.

Buying and validating

For a cleavage-specific reagent, demand evidence that it does not detect the precursor: a lane of untreated lysate should be clean. That single control separates a genuinely specific antibody from one sold as specific.

Bank one lot for the study and record it with every experiment. Cleavage-specific polyclonals in particular vary between bleeds in how well they discriminate.

Common questions

Should I buy a total or a cleaved caspase 3 antibody?

Cleaved, for measuring apoptosis. The precursor is present in healthy cells, so a total antibody shows little change; the cleavage-specific reagent recognises the neoepitope created by activation.

How is an hmgb1 antibody result read?

By location. It is nuclear in healthy cells and moves to the cytoplasm and out of the cell during certain death pathways, so a nuclear to cytoplasmic ratio or a measurement in the medium is the readout, not a whole-cell level.

What controls does a cell death experiment need?

A vehicle control from the same plate, a known inducer as a positive control, a viability measure, and a baseline death rate reported rather than hidden. Without those a difference cannot be attributed to the treatment.

Why do my untreated cells show death markers?

Ordinary culture stress: over-confluence, exhausted medium, a rough thaw or handling. Measure and report the baseline; a treatment that raises death from a high baseline is a much weaker result than one that raises it from a low one.

Browse by service class

• Compare Gene synthesis on advertised prices